# Innate Pharma SA: Form 20-F for the period ended Dec 31, 2019

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 20-F
- Filed: 2020-04-24
- Accepted by EDGAR: Apr 24, 2020, 10:43 ET
- Period: 2019-12-31
- Accession: 0001171843-20-002847
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000117184320002847/f20f_042420.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000117184320002847/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2019-01-01 to 2019-12-31 | EUR 85.8m | ifrs-full:Revenue |
| Operating income | 12 months, 2019-01-01 to 2019-12-31 | −EUR 27.1m | ifrs-full:ProfitLossFromOperatingActivities |
| Net income | 12 months, 2019-01-01 to 2019-12-31 | −EUR 20.8m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2019-01-01 to 2019-12-31 | −EUR 0.31 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2019-01-01 to 2019-12-31 | −EUR 0.31 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2019-01-01 to 2019-12-31 | EUR 34.9m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2019-01-01 to 2019-12-31 | EUR 1.3m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2019-12-31 | EUR 202.9m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2019-12-31 | EUR 237.6m | ifrs-full:CurrentAssets |
| Total assets | at 2019-12-31 | EUR 401.4m | ifrs-full:Assets |
| Current liabilities | at 2019-12-31 | EUR 121.8m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | at 2019-12-31 | EUR 217.4m | ifrs-full:Equity |
| Shares outstanding | at 2019-12-31 | 78,580,464 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000117184320002847/f20f_042420.htm

Filed Apr 24, 2020.
Source: SEC EDGAR, the filing index for accession 0001171843-20-002847. Last ingested by Listed: Nov 5, 2026, 11:30 ET. No prices; not investment advice.